MicroRNA-205-directed transcriptional activation of tumor suppressor genes in prostate cancer

Cancer

Volumn 116, Issue 24, 2010, Pages 5637-5649

  Majid, Shahana ^a   Dar, Altaf A ^b   Saini, Sharanjot ^a   Yamamura, Soichiro ^a   Hirata, Hiroshi ^a   Tanaka, Yuichiro ^a   Deng, Guoren ^a   Dahiya, Rajvir ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

IL24; IL32; microRNA 205; prostate cancer; transcriptional activation

Indexed keywords

INTERLEUKIN 24; INTERLEUKIN 32; MICRORNA; MICRORNA 205; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE ARREST; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IL24 GENE; IL32 GENE; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROSTATE HYPERTROPHY; TRANSCRIPTION INITIATION; TUMOR SUPPRESSOR GENE;

CELL LINE, TUMOR; CELL SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; INTERLEUKINS; MALE; MICRORNAS; NEOPLASM INVASIVENESS; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; TRANSCRIPTIONAL ACTIVATION;

EID: 78650117232     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25488     Document Type: Article

References (38)

1. Friedman RC, Farh KK, Burge CB, Bartel DP., Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009; 19: 92-105.
2. Lewis BP, Burge, CB, Bartel DP., Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005; 120: 15-20.
3. Carrington JC, Ambros V., Role of microRNAs in plant and animal development. Science. 2003; 301: 336-338.
4. Kloosterman WP, Plasterk RH., The diverse functions of microRNAs in animal development and disease. Dev Cell. 2006; 11: 441-450.
5. Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature. 2005; 435: 834-838.
6. Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006; 103: 2257-2261.
7. Esquela-Kerscher A, Slack FJ., Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer. 2006; 6: 259-269.
8. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ., Cancer statistics, 2009. CA Cancer J Clin. 2009; 59: 225-249.
9. Mimeault M, Batra SK., Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies. Carcinogenesis. 2006; 27: 1-22.
10. Shi XB, Tepper CG, White RW., MicroRNAs and prostate cancer. J Cell Mol Med. 2008; 12: 1456-1465.
11. Gottardo F, Liu CG, Ferracin M, et al. Micro-RNA profiling in kidney and bladder cancers. Urol Oncol. 2007; 25: 387-392.
12. Iorio MV, Visone R, Di Leva G, et al. MicroRNA signatures in human ovarian cancer. Cancer Res. 2007; 67: 8699-8707.
13. Feber A, Xi L, Luketich JD, et al. MicroRNA expression profiles of esophageal cancer. J Thorac Cardiovasc Surg. 2008; 135: 255-260: discussion 260.
14. Sempere LF, Christensen M, Silahtaroglu A, et al. Altered microRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res. 2007; 67: 11612-11620.
15. He L, Hannon GJ., MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004; 5: 522-531.
16. Jiang H, Lin JJ, Su ZZ, Goldstein NI, Fisher PB., Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene. 1995; 11: 2477-2486.
17. Saeki T, Mhashilkar A, Chada S, Branch C, Roth JA, Ramesh R., Tumor-suppressive effects by adenovirus-mediated mda-7 gene transfer in non-small cell lung cancer cell in vitro. Gene Ther. 2000; 7: 2051-2057.
18. Su ZZ, Madireddi MT, Lin JJ, et al. The cancer growth suppressor gene mda-7 selectively induces apoptosis in human breast cancer cells and inhibits tumor growth in nude mice. Proc Natl Acad Sci U S A. 1998; 95: 14400-14405.
19. Mhashilkar AM, Schrock RD, Hindi M, et al. Melanoma differentiation associated gene-7 (mda-7): a novel anti-tumor gene for cancer gene therapy. Mol Med. 2001; 7: 271-282.
20. Chada S, Sutton RB, Ekmekcioglu S, et al. MDA-7/IL-24 is a unique cytokine-tumor suppressor in the IL-10 family. Int Immunopharmacol. 2004; 4: 649-667.
21. Su Z, Emdad L, Sauane M, et al. Unique aspects of mda-7/IL-24 antitumor bystander activity: establishing a role for secretion of MDA-7/IL-24 protein by normal cells. Oncogene. 2005; 24: 7552-7566.
22. Su ZZ, Lebedeva IV, Sarkar D, et al. Melanoma differentiation associated gene-7, mda-7/IL-24, selectively induces growth suppression, apoptosis and radiosensitization in malignant gliomas in a p53-independent manner. Oncogene. 2003; 22: 1164-1180.
23. Ramesh R, Mhashilkar AM, Tanaka F, et al. Melanoma differentiation- associated gene 7/interleukin (IL)-24 is a novel ligand that regulates angiogenesis via the IL-22 receptor. Cancer Res. 2003; 63: 5105-5113.
24. Kim SH, Han SY, Azam T, Yoon DY, Dinarello CA., Interleukin-32: a cytokine and inducer of TNFalpha. Immunity. 2005; 22: 131-142.
25. Goda C, Kanaji T, Kanaji S, et al. Involvement of IL-32 in activation-induced cell death in T cells. Int Immunol. 2006; 18: 233-240.
26. Majid S, Dar AA, Shahryari V, et al. Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene B-cell translocation gene 3 in prostate cancer. Cancer. 2010; 116: 66-76.
27. Majid S, Kikuno N, Nelles J, et al. Genistein induces the p21WAF1/CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification. Cancer Res. 2008; 68: 2736-2744.
28. Torabian SZ, de Semir D, Nosrati M, et al. Ribozyme-mediated targeting of IkappaBgamma inhibits melanoma invasion and metastasis. Am J Pathol. 2009; 174: 1009-1016.
29. Kim DH, Saetrom P, Snove O Jr, Rossi JJ., MicroRNA-directed transcriptional gene silencing in mammalian cells. Proc Natl Acad Sci U S A. 2008; 105: 16230-16235.
30. Li LC, Okino ST, Zhao H, et al. Small dsRNAs induce transcriptional activation in human cells. Proc Natl Acad Sci U S A. 2006; 103: 17337-17342.
31. Janowski BA, Younger ST, Hardy DB, Ram R, Huffman KE, Corey DR., Activating gene expression in mammalian cells with promoter-targeted duplex RNAs. Nat Chem Biol. 2007; 3: 166-173.
32. Porkka KP, Pfeiffer MJ, Waltering KK, Vessella RL, Tammela TL, Visakorpi T., MicroRNA expression profiling in prostate cancer. Cancer Res. 2007; 67: 6130-6135.
33. Gandellini P, Folini M, Longoni N, et al. miR-205 exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase C epsilon. Cancer Res. 2009; 69: 2287-2295.
34. Heintzman ND, Stuart RK, Hon G, et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet. 2007; 39: 311-318.
35. Guenther MG, Levine SS, Boyer LA, Jaenisch R, Young RA., A chromatin landmark and transcription initiation at most promoters in human cells. Cell. 2007; 130: 77-88.
36. Landgraf P, Rusu M, Sheridan R, et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell. 2007; 129: 1401-1414.
37. Li B, Carey M, Workman JL., The role of chromatin during transcription. Cell. 2007; 128: 707-719.
38. Bernstein BE, Kamal M, Lindblad-Toh K, et al. Genomic maps and comparative analysis of histone modifications in human and mouse. Cell. 2005; 120: 169-181.